跳至主要内容
临床试验/NCT04953156
NCT04953156已完成不适用

A Comparative Study Between Nitroglycerine Infusion and Dexmedetomidine Infusion in Intraoperative Management of Uncontrolled Hypertension

National Cancer Institute, Egypt1 个研究点 分布在 1 个国家目标入组 77 人开始时间: 2021年7月3日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
77
试验地点
1
主要终点
Intraoperative blood pressure values

研究概览

简要总结

This study aim to compare the efficacy of intraoperative dexmedetomidine infusion versus Nitroglycerin infusion in cancer patients with accidental uncontrolled intraoperative elevation of blood pressure.

详细描述

Nitroglycerine is a direct vessel wall vasodilator with more venodilator effect than arterial dilator effect. It is used as an anti-anginal and antihypertensive drug. On the other hand, dexmedetomidine is a highly selective alpha 2 adrenergic agonist with sympatholytic effect. This study aim to compare the efficacy of intraoperative dexmedetomidine infusion versus Nitroglycerin infusion in cancer patients with accidental uncontrolled intraoperative elevation of blood pressure.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Cancer patients with controlled hypertension and undergoing surgical procedures under general anesthesia
  • ≥ Age 18 years.

排除标准

  • patient refusal
  • patients on Beta blockers
  • kidney or liver function impairment
  • bradycardia, any degree of heart block and severe cardiorespiratory disease

研究组 & 干预措施

Nitroglycerin

data of patients meeting the eligibility criteria and received nitroglycerine infusion will be retrieved from medical records.

干预措施: Nitroglycerin (Drug)

Dexmedetomidine

patients will receive dexmedetomidine bolus dose of 1 mic/kg over 20 minutes followed by intravenous infusion of 0.2-0.7 mic/kg/hr adjusted according to each patient hemodynamic response

干预措施: Dexmedetomidine (Drug)

结局指标

主要结局

Intraoperative blood pressure values

时间窗: Intraoperative period

measurements of blood pressure

次要结局

  • Intraoperative heart rate values(operative time)

研究者

发起方
National Cancer Institute, Egypt
申办方类型
Other
责任方
Principal Investigator
主要研究者

Walaa Youssef Elsabeeny

Lecturer of Anesthesia and Pain management

National Cancer Institute, Egypt

研究点 (1)

Loading locations...

相似试验